Biotech · Private company · Rancho Dominguez, CA, US

Molecular Express, Inc.

Track this companyFree. Adds Molecular Express, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Preclinical Development of a ME-1001, a Synthetic Lung SurfactantFiscal year 2025 · $999.8KNIH RePORTER 5R44HL172526-02 · fetched Nov 12, 2026
Preclinical Development of a ME-1001, a Synthetic Lung SurfactantFiscal year 2024 · $999.9KNIH RePORTER 1R44HL172526-01A1 · fetched Nov 12, 2026
VESIVAX TLR7 FORMULAFiscal year 2024 · $3MNIH RePORTER 75N93024C00017-0-9999-1 · fetched Nov 12, 2026
Design and Engineering of VesiVax HIV Immunogen FormulationsFiscal year 2024 · $2MNIH RePORTER 75N93024C00018-0-9999-1 · fetched Nov 12, 2026